Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaccine alliance Gavi says that additional $5.2bn needed to ensure supply

January 20, 2022
Business Services

The chairman of the Gavi vaccine alliance, Jose Manuel Barroso, has said that an additional $5.2 billion is required to …

News

Engitix and Dompé collaboration for fibrosis and cancer AI drug discovery

January 19, 2022
Research and Development

Engitix has announced the close of its $54m Series A financing, as well as a strategic collaboration, with Dompé farmaceutici …

News
e-6olmfwuay74lr

MHRA license Jyseleca for treatment of ulcerative colitis

January 19, 2022
Research and Development

Galapagos NV, the Belgian parent company of Galapagos Biotech Ltd, have announced that Jyseleca® (filgotinib 200mg tablets) has been granted …

News

UK launch of generic lenalidomide for myeloma

January 19, 2022
Research and Development

Accord Healthcare have announced the UK launch of generic lenalidomide, available for the treatment of adult patients with multiple myeloma, …

News

SMC accepts first-line treatment for lung cancer

January 19, 2022
Research and Development

The SMC has accepted AstraZeneca’s Tagrisso (osimertinib) for use as monotherapy for the first-line treatment of adult patients with locally …

News

Julie Beeso joins Envision Pharma Group as new Global Director

January 18, 2022
Manufacturing and Production

Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement. Julie has worked for almost …

Appointment
mario_torchia_ist

Mario Torchia appointed as new Vice President of Sales & Marketing at InSilicoTrials

January 18, 2022
Manufacturing and Production

InSilicoTrials, a leader in simulation software solutions for healthcare, has announced Mario Torchia’s appointment. Torchia recently led the Sales Strategy …

Appointment

Enhertu granted priority review in US for patients with HER2-positive metastatic breast cancer

January 18, 2022
Manufacturing and Production

Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with …

News

SMC accept Enhertu for the treatment of HER2 positive metastatic breast cancer

January 18, 2022
Manufacturing and Production

Daiichi Sankyo and AstraZeneca have announced that the SMC has accepted Enhertu® for use within NHS Scotland for the treatment …

News
andrei_r_-_shutterstock_1935537274_720

Almirall and IRB Barcelona research for skin disease therapeutics discovery

January 18, 2022
Manufacturing and Production

Almirall and IRB Barcelona (the Institute for Research in Biomedicine) have announced a research collaboration to identify the new oral …

News

Abbisko Therapeutics collaborates with Lilly to discover novel molecules

January 18, 2022
Manufacturing and Production

Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This …

News

Neurimmune and Ono Pharmaceutical collaborate to research neurodegenerative diseases

January 17, 2022
Sales and Marketing

Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical. The companies aim to focus on creating …

News

NICE draft guidance recommends new treatment for rare liver condition

January 17, 2022
Sales and Marketing

On Friday 14 January, NICE published a final draft Highly Specialised Technologies guidance, recommending odevixibat in line with its marketing …

News

FDA places Alzheimer’s therapeutic IND Application on hold

January 17, 2022
Sales and Marketing

The FDA has placed a hold on the Investigational New Drug (IND) application for DNL919, indicating they will provide an …

News

COVID-19 self-isolation cut to five full days in England

January 17, 2022
Sales and Marketing

The minimum self-isolation period for people testing positive for COVID-19 in England has been cut from seven days to five …

News

AstraZeneca and Scorpion strike $1.5bn deal against hard-to-treat proteins

January 14, 2022
Medical Communications

AstraZeneca and Scorpion have partnered to develop precision medicines against previously hard-to-target cancer proteins. The collaboration, valued at more than …

News

South Africa study shows J&J booster 85% effective against Omicron hospitalisation

January 14, 2022
Medical Communications

The head of South Africa’s Medical Research Council (SAMRC) has revealed that a J&J booster shot is 85% effective in …

News

First melanoma test to offer reassurance of low risk of cancer spread

January 14, 2022
Medical Communications

A new test reliably predicting the spread or return of the most deadly form of skin cancer has been developed …

News

WHO recommend two new COVID-19 treatments

January 14, 2022
Medical Communications

WHO approved two new treatments for COVID-19 on 14 January, as Omicron cases continue globally, and WHO predicting half of …

News

Benevolent AI and AstraZeneca expand collaboration on heart failure and systemic lupus discovery

January 13, 2022
Business Services

Leading clinical stage AI drug discovery company, Benevolent AI, has expanded its AI-driven drug discovery collaboration with AstraZeneca. This means …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026